Delineation of the minimal region of loss at 13q14 in multiple myeloma MO Elnenaei, RA Hamoudi, J Swansbury, AM Gruszka‐Westwood, ... Genes, Chromosomes and Cancer 36 (1), 99-106, 2003 | 94 | 2003 |
Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation MO Elnenaei, R Chandra, T Mangion, C Moniz British journal of nutrition 105 (1), 71-79, 2011 | 70 | 2011 |
Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A MO Elnenaei, AM Gruszka-Westwood, R A'Hernt, E Matutes, B Sirohi, ... Haematologica 88 (5), 529-537, 2003 | 59 | 2003 |
Translocation t (2; 7)(p12; q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin’s lymphoma with leukemia V Brito-Babapulle, AM Gruszka-Westwood, G Platt, CL Andersen, ... | 51 | 2002 |
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies MO Elnenaei, DM Jadayel, E Matutes, R Morilla, K Owusu-Ankomah, ... Leukemia research 25 (2), 115-123, 2001 | 48 | 2001 |
Predicting refeeding hypophosphataemia: insulin growth factor 1 (IGF-1) as a diagnostic biochemical marker for clinical practice A Goyale, SL Ashley, DR Taylor, MO Elnenaei, J Alaghband-Zadeh, ... Annals of clinical biochemistry 52 (1), 82-87, 2015 | 43 | 2015 |
Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene AM Gruszka‐Westwood, S Atkinson, BM Summersgill, J Shipley, ... Genes, Chromosomes and Cancer 33 (2), 206-212, 2002 | 41 | 2002 |
Evaluation of the impact of a total automation system in a large core laboratory on turnaround time AH Lou, MO Elnenaei, I Sadek, S Thompson, BD Crocker, B Nassar Clinical Biochemistry 49 (16-17), 1254-1258, 2016 | 40 | 2016 |
An effective utilization management strategy by dual approach of influencing physician ordering and gate keeping MO Elnenaei, SG Campbell, AJ Thoni, A Lou, BD Crocker, BA Nassar Clinical Biochemistry 49 (3), 208-212, 2016 | 39 | 2016 |
Multiple pre-and post-analytical lean approaches to the improvement of the laboratory turnaround time in a large core laboratory AH Lou, MO Elnenaei, I Sadek, S Thompson, BD Crocker, BA Nassar Clinical biochemistry 50 (15), 864-869, 2017 | 36 | 2017 |
Leptin and insulin growth factor 1: diagnostic markers of the refeeding syndrome and mortality MO Elnenaei, J Alaghband-Zadeh, R Sherwood, MA Awara, C Moniz, ... British journal of nutrition 106 (6), 906-912, 2011 | 28 | 2011 |
Targeting NAD+ synthesis to potentiate CD38-based immunotherapy of multiple myeloma BE Kennedy, M Sadek, MO Elnenaei, A Reiman, SA Gujar Trends in Cancer 6 (1), 9-12, 2020 | 15 | 2020 |
The effect of time of day testing and utility of 30 and 60 minute cortisol values in the 250 mcg ACTH stimulation test V Munro, M Elnenaei, S Doucette, DB Clarke, SA Imran Clinical Biochemistry 54, 37-41, 2018 | 15 | 2018 |
Postprandial bone turnover is independent of calories above 250 kcal MO Elnenaei, R Musto, J Alaghband-Zadeh, C Moniz, CW Le Roux Annals of clinical biochemistry 47 (4), 318-320, 2010 | 13 | 2010 |
Reflex and reflective testing strategies for early detection of pituitary dysfunction M Elnenaei, D Minney, DB Clarke, A Kumar-Misir, SA Imran Clinical Biochemistry 54, 78-84, 2018 | 12 | 2018 |
Adherence to the National Institute of Clinical Excellence guidance on parenteral nutrition screening is not enough to improve outcomes RP Vincent, S Omar, MO Elnenaei, CH Goo, R Salota, PF Wu, ... Clinical nutrition 32 (1), 73-76, 2013 | 7 | 2013 |
Low‐depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution MO Elnenaei, P Knopf, SD Cutler, K Sinclair, M Abou El Hassan, W Greer, ... Clinical Genetics 96 (2), 163-168, 2019 | 6 | 2019 |
Diurnal rhythm in clinical chemistry: An underrated source of variation M Abou El Hassan, E Delvin, MO Elnenaei, B Hoffman Critical Reviews in Clinical Laboratory Sciences 55 (8), 516-534, 2018 | 6 | 2018 |
Rapid cycling bipolar affective disorder and recurrent strokes secondary to high blood homocysteine MA Awara, S Zahid, MO Elnenaei Journal of Mental Health 23 (5), 276-279, 2014 | 5 | 2014 |
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma BE Kennedy, M Giacomantonio, JP Murphy, S Cutler, M Sadek, P Konda, ... Molecular Therapy-Oncolytics 24, 695-706, 2022 | 4 | 2022 |